文献速递药物相互作用

微剂量Xa因子抑制剂鸡尾酒法研究药物相互作用

Application of a microdosed cocktail of 3 oral factor Xa inhibitors to study drug-drug interactions with different perpetrator drugs.
PubMed 文献 · Br J Clin Pharmacol · 2020-03-27

本研究在健康志愿者中评估微剂量Xa因子抑制剂(利伐沙班、阿哌沙班、艾多沙班各100 μg)鸡尾酒法研究药物相互作用的适用性。三组各6名受试者分别合用伏立康唑、考比司他或单剂利福平。考比司他显著增加三种FXaI暴露,利福平降低其分布容积和消除半衰期,伏立康唑仅与阿哌沙班和利伐沙班有轻微相互作用。

要点

  • 微剂量FXaI鸡尾酒法可安全同时研究一类药物的药物相互作用。
  • 考比司他显著增加阿哌沙班、艾多沙班和利伐沙班暴露。
  • 单剂利福平降低三种FXaI的分布容积和消除半衰期。

核心结论

  • 微剂量FXaI鸡尾酒法能生成药物相互作用数据,有助于阐明不同底物药物的清除机制。
  • 该方法是同时研究一类药物药物相互作用的安全方法。

研究设计与样本

  • 三个队列各6名健康志愿者,分别接受单独微剂量FXaI及合用一种肇事药物的两阶段治疗。
  • 微剂量FXaI鸡尾酒含利伐沙班、阿哌沙班和艾多沙班,总量100 μg。
  • 采用 validated UPLC-MS/MS 定量血浆和尿液中微剂量药物,定量下限为2.5 pg/mL。

主要发现

  • 伏立康唑仅与阿哌沙班和利伐沙班发生轻微相互作用,与艾多沙班无相互作用。
  • 考比司他显著增加全部三种FXaI暴露,AUC比值:阿哌沙班1.67、艾多沙班1.74、利伐沙班2.0。
  • 单剂利福平降低全部三种FXaI的分布容积和消除半衰期。

临床怎么用

  • 微剂量FXaI鸡尾酒法可用于临床药物相互作用研究,同时评估一类药物的相互作用。
  • 结果提示考比司他显著增加FXaI暴露,利福平改变其药代动力学参数。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Using 3 different perpetrators the impact of voriconazole, cobicistat and rifampicin (single dose), we evaluated the suitability of a microdose cocktail of factor Xa inhibitors (FXaI; rivaroxaban, apixaban and edoxaban; 100 μg in total) to study drug-drug interactions. METHODS: Three cohorts of 6 healthy volunteers received 2 treatments with microdoses of rivaroxaban, apixaban and edoxaban alone and with coadministration of 1 of the perpetrators. Plasma and urine concentrations of microdosed apixaban, edoxaban and rivaroxaban were quantified using a validated ultra-performance liquid chromatography-tandem mass spectrometry with a lower limit of quantification of 2.5 pg/mL. RESULTS: Voriconazole caused only a minor interaction with apixaban and rivaroxaban, none with edoxaban. Cobicistat significantly increased exposure of all 3 FXaI with area under the plasma concentration-time curve ratios of 1.67 (apixaban), 1.74 (edoxaban) and 2.0 (rivaroxaban). A single dose of rifampicin decreased the volume of distribution and elimination half-life of all 3 FXaI. CONCLUSIONS: The microdosed FXaI cocktail approach is able to generate drug interaction data and can help elucidating the mechanism involved in the clearance of the different victim drugs. This is a safe approach to concurrently study drug-drug interactions with a drug class. (EudraCT 2016-003024-23).

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Mikus G, Foerster KI, Schaumaeker M, et al. Application of a microdosed cocktail of 3 oral factor Xa inhibitors to study drug-drug interactions with different perpetrator drugs. Br J Clin Pharmacol. 2020. PMID: 32159869. doi:10.1111/bcp.14277

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。